Tickling the TLR7 to cure viral hepatitis

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A comprehensive hepatitis C viral kinetic model explaining cure.

We propose a model that characterizes and links the complexity and diversity of clinically observed hepatitis C viral kinetics to sustained virologic response (SVR)-the primary clinical end point of hepatitis C treatment, defined as an undetectable viral load at 24 weeks after completion of treatment)-in patients with chronic hepatitis C (CHC) who have received treatment with peginterferon alph...

متن کامل

Tickling

A quick guide to tickling, a form of laughter-evoking play that can be considered as an index of agency, with a discussion of its taxonomic distribution and its possible relationship to traditional measures of self-recognition.

متن کامل

CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection

Immunological checkpoints, such as the inhibitory CD200 receptor (CD200R), play a dual role in balancing the immune system during microbial infection. On the one hand these inhibitory signals prevent excessive immune mediated pathology but on the other hand they may impair clearance of the pathogen. We studied the influence of the inhibitory CD200-CD200R axis on clearance and pathology in two d...

متن کامل

TLR7: A new sensor of viral infection.

T he preponderance of mammalian resistance to infection is inherited rather than acquired. Even without lymphoid cells, mammals still protect themselves. They respond violently to bacteria, fungi, and viruses; or, more precisely, to specific molecular components of these organisms. Most of the molecular targets for recognition have been known for decades (1). However, only recently have the rec...

متن کامل

Another Call to Cure Hepatitis B

Because curing chronic hepatitis B is not yet possible, reactivation of hepatitis B virus (HBV) occurs and is most commonly recognized in the setting of immunosuppression [1]. In this issue of Clinical Infectious Diseases, Collins et al give us another setting to monitor for HBV reactivation—curing hepatitis C with directacting antiviral agents (DAAs) in HBV/ hepatitis C virus (HCV) coinfection...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Translational Medicine

سال: 2014

ISSN: 1479-5876

DOI: 10.1186/1479-5876-12-129